Literature DB >> 9449239

Estrogen receptor variants and mutations.

L C Murphy1, H Dotzlaw, E Leygue, D Douglas, A Coutts, P H Watson.   

Abstract

There is a large and increasing body of experimental and clinical data supporting the existence or variant estrogen receptor (ER) proteins in both normal and neoplastic estrogen target tissues including human breast. Therefore, future examination of ER signal transduction and/or measurement of ER protein must take into account variant ER expression. The functions of variant ER proteins, either physiological or pathological, remain unclear, although a role(s) for some ER variants in breast tumorigenesis and breast cancer progression would be consistent with the accumulated data. Possible tissue specific expression leads to the speculation that ER variants may have a role in tissue specific estrogen action. The following review focuses on the current knowledge available in the scientific literature with respect to the type and characteristics of estrogen receptor variants and mutations that have been identified to occur naturally in tissues and cell lines.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9449239     DOI: 10.1016/s0960-0760(97)00084-8

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  15 in total

Review 1.  Interindividual differences in phytochemical metabolism and disposition.

Authors:  Johanna W Lampe; Jyh-Lurn Chang
Journal:  Semin Cancer Biol       Date:  2007-05-13       Impact factor: 15.707

2.  Estrogen receptors in human preadipocytes.

Authors:  J M Joyner; L J Hutley; D P Cameron
Journal:  Endocrine       Date:  2001-07       Impact factor: 3.633

3.  Estrogen receptor genes variations and breast cancer risk in Iran.

Authors:  Sakineh Abbasi; Mehrnaz Nouri; Cyrus Azimi
Journal:  Int J Clin Exp Med       Date:  2012-08-25

4.  Phosphorylation of Estrogen Receptor α at serine 118 directs recruitment of promoter complexes and gene-specific transcription.

Authors:  Tamika T Duplessis; Christopher C Williams; Steven M Hill; Brian G Rowan
Journal:  Endocrinology       Date:  2011-04-19       Impact factor: 4.736

5.  Estrogen receptor variants in epithelial compartment of normal human breast.

Authors:  J Yang; A Liu; R Guzman; S Nandi
Journal:  Endocrine       Date:  2000-06       Impact factor: 3.633

6.  Do Estrogen Receptor beta Polymorphisms Play A Role in the Pharmacogenetics of Estrogen Signaling?

Authors:  Stephanie L Nott; Yanfang Huang; Brian R Fluharty; Anna M Sokolov; Melinda Huang; Cathleen Cox; Mesut Muyan
Journal:  Curr Pharmacogenomics Person Med       Date:  2008-12-01

7.  Twist contributes to hormone resistance in breast cancer by downregulating estrogen receptor-α.

Authors:  F Vesuna; A Lisok; B Kimble; J Domek; Y Kato; P van der Groep; D Artemov; J Kowalski; H Carraway; P van Diest; V Raman
Journal:  Oncogene       Date:  2011-11-07       Impact factor: 9.867

8.  The estrogen receptor-alpha A908G (K303R) mutation occurs at a low frequency in invasive breast tumors: results from a population-based study.

Authors:  Kathleen Conway; Eloise Parrish; Sharon N Edmiston; Dawn Tolbert; Chiu-Kit Tse; Joseph Geradts; Chad A Livasy; Harsharan Singh; Beth Newman; Robert C Millikan
Journal:  Breast Cancer Res       Date:  2005-09-06       Impact factor: 6.466

Review 9.  Estrogen receptor transcription and transactivation: Basic aspects of estrogen action.

Authors:  S Nilsson; J A Gustafsson
Journal:  Breast Cancer Res       Date:  2000-07-13       Impact factor: 6.466

10.  Risk factors for breast cancer characterized by the estrogen receptor alpha A908G (K303R) mutation.

Authors:  Kathleen Conway; Eloise Parrish; Sharon N Edmiston; Dawn Tolbert; Chiu-Kit Tse; Patricia Moorman; Beth Newman; Robert C Millikan
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.